How is the Inhibikase Therapeutics Inc today?

The Inhibikase Therapeutics Inc today is trading in the down by 0.00% at 1.98.

How has Inhibikase Therapeutics Inc performed historically?

The Inhibikase Therapeutics Inc is currently trading down 0.00% on an intraday basis in the past week the index fell -2.94%. The index has been down -10.00% in the past quarter and rose 8.79% in the past year. You can view this in the overview section.

What is Inhibikase Therapeutics Inc Annual Net Profit?

Inhibikase Therapeutics Inc Annual Net Profit fell 44.62% in the last year to $27.52 M. Its sector's average net profit growth for the last fiscal year was -13.86%.

What is Inhibikase Therapeutics Inc Price to Earning Ratio?

Inhibikase Therapeutics Inc Price to Earning Ratio is -4.03, which is negative.

What is Inhibikase Therapeutics Inc Stock Price?

Inhibikase Therapeutics Inc Stock Price rose 8.79% and underperformed its sector by 18.49% in the past year.

What is Inhibikase Therapeutics Inc Quarterly Net profit?

Inhibikase Therapeutics Inc Quarterly Net profit fell 194.19% YoY to $13.68 M. Its sector's average net profit growth YoY for the quarter was -238.4%.

What is Inhibikase Therapeutics Inc Debt to Equity Ratio?

Inhibikase Therapeutics Inc Debt to Equity Ratio is zero as the company is debt-free.

What is Inhibikase Therapeutics Inc Return on Equity(ROE)?

Inhibikase Therapeutics Inc Return on Equity(ROE) for the last financial year was -52%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Inhibikase Therapeutics Inc Mutual Fund Holding?

Inhibikase Therapeutics Inc Mutual Fund Holding decreased by 0.09% in the last quarter to 4.78.

What is Inhibikase Therapeutics Inc Institutional Holding?

Inhibikase Therapeutics Inc Institutional Holding decreased by 0.08% in the last quarter to 69.13.

Inhibikase Therapeutics Inc XNAS: IKT

Inhibikase Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Name: Inhibikase Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Inhibikase Therapeutics Inc
Rating: 1.26100
Author: Trendlyne DVM scores

about

Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease (PD), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinas...

1.98 0.00 (0.00%)

52.86% Fall from 52W High

8,606 XNAS Volume

XNAS 05 Jun, 2025 10:22 AM (EDT)

Board Meeting

The next board meeting for Inhibikase Therapeutics Inc is on 06 Jun 2025 for the purpose of Inhibikase Therapeutics Inc Annual General Meeting for 2025 See details

Not Eligible

Expensive Valuation

9.5 / 100

Technically Neutral

40.9 / 100

No estimates available

Inhibikase Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Inhibikase Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease (PD), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinas...

52.86% Fall from 52W High

SWOT Analysis

Inhibikase Therapeutics Inc Live Price Chart

Inhibikase Therapeutics Inc FAQ

How is Inhibikase Therapeutics Inc today?

Inhibikase Therapeutics Inc today is trading in the red, and is down by 0.00% at 1.98.

How has Inhibikase Therapeutics Inc performed historically?

Inhibikase Therapeutics Inc is currently trading down 0.00% on an intraday basis. In the past week the stock fell -2.94%. stock has been down -10.00% in the past quarter and rose 8.79% in the past year. You can view this in the overview section.